World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
94
Citations
35621
World Ranking
1993
National Ranking
1086

Peter Bohlen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Peter Bohlen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 198 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Peter Bohlen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Bohlen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 94 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Peter Bohlen is affiliated with Eli Lilly in the United States. Their research activity spans fields including Biochemistry, Genetics and Molecular Biology, as well as Engineering. Specific subfields of study include Clinical Biochemistry, Biomedical Engineering, and Biophysics.

The topics central to Bohlen's research revolve around areas such as Bacterial Identification and Susceptibility Testing, Biosensors and Analytical Detection, and Cell Image Analysis Techniques.

One recent publication by Bohlen appeared in 2022, titled "885. Integrated Blood Culture and Molecular Diagnostic Device Reduces Time-to-Result to a Quarter of Traditional Methods," published in Open Forum Infectious Diseases.

  • Laura Huning
  • Devika M. Varma
  • Abbey Jackson
  • Rainer Ng
  • Vamsee K. Pamula

  • Open Forum Infectious Diseases

Best Publications

  • Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.

    Roger Guillemin;Paul Brazeau;Peter Bohlen;Frederick Esch

  • Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

    Giannoula Klement;Sylvain Baruchel;Janusz Rak;Shan Man

  • Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

    Aernout Luttun;Marc Tjwa;Lieve Moons;Yan Wu

  • Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

    Marijke Frater-Schroder;Werner Risau;Rupert Hallmann;Peter Gautschi

  • Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

    Frederick Esch;Andrew Baird;Nicholas Ling;Naoto Ueno

  • Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.

    Scott T. Avecilla;Koichi Hattori;Beate Heissig;Rafael Tejada

  • Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1 + stem cells from bone-marrow microenvironment

    Koichi Hattori;Beate Heissig;Yan Wu;Sergio Dias

  • Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

    Marie Prewett;James Huber;Yiwen Li;Angel Santiago

  • Acquired Resistance to the Antitumor Effect of Epidermal Growth Factor Receptor-blocking Antibodies in Vivo A Role for Altered Tumor Angiogenesis

    Alicia Viloria-Petit;Tania Crombet;Serge Jothy;Daniel Hicklin

  • Fibroblast growth factor

    Frederick Stephen Esch;Andrew Baird;Peter Dr. Bohlen;Denis Jersy Gospodarowicz

  • Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

    Philip Kunkel;Ulrike Ulbricht;Peter Bohlen;Marc A. Brockmann

  • Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy.

    Larry Witte;Daniel J. Hicklin;Zhenping Zhu;Bronislaw Pytowski

  • Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor.

    Andrew Baird;Pierre Mormède;Peter Bőhlen

  • Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues.

    Andrew Baird;Frederick Esch;Pierre Mormede;Naoto Ueno

  • A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

    Douglas Burtrum;Zhenping Zhu;Dan Lu;Donna Marie Anderson

  • Inhibitory action of transforming growth factor beta on endothelial cells

    Gertraud Muller;Jurgen Behrens;Ute Nussbaumer;Peter Bohlen

  • Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability.

    Monica Corada;Fang Liao;Maria Lindgren;Maria Grazia Lampugnani

  • Vascular Endothelial Growth Factor Receptor-2-blocking Antibody Potentiates Radiation-induced Long-Term Control of Human Tumor Xenografts

    Sergey V. Kozin;Yves Boucher;Daniel J. Hicklin;Peter Bohlen

  • Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

    Shan Man;Guido Bocci;Giulio Francia;Shane K. Green

  • Transforming growth factor-beta inhibits endothelial cell proliferation

    Marijke Fràter-Schröder;Gertraud Müller;Walter Birchmeier;Peter Böhlen

Frequent Co-Authors

Daniel J. Hicklin
Daniel J. Hicklin Eli Lilly (United States)
Frederick Esch
Frederick Esch Salk Institute for Biological Studies
Nicholas Ling
Nicholas Ling Salk Institute for Biological Studies
Roger Guillemin
Roger Guillemin Salk Institute for Biological Studies
Andrew Baird
Andrew Baird University of California, San Diego
Denis Gospodarowicz
Denis Gospodarowicz University of California, San Francisco
Shahin Rafii
Shahin Rafii Cornell University
Jan Kitajewski
Jan Kitajewski Columbia University
Elisabetta Dejana
Elisabetta Dejana Uppsala University
Meilin Liu
Meilin Liu Georgia Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry often opens doors to a wide range of dynamic healthcare professions and graduate studies. The growing availability of online degrees means students can now specialize in vital health fields with increased flexibility and speed. For instance, those interested in mental health may want to consider the fastest psych np program, which offers an accelerated track to advanced clinical roles.

Alternatively, nutrition is a critical domain for many biology students. You can pursue a 2 year nutrition degree online, making it accessible for aspiring dietitians and health coaches to quickly enter the field.

For those interested in leadership and business, an online healthcare mba can pave the way for roles in health administration and policy. Lastly, biology backgrounds also align well with health information careers. Understanding medical coding certification options can help students prepare for in-demand coding and billing roles.

With so many online pathways available, students can choose options that match their career interests and timelines.

Best Scientists Citing Peter Bohlen

Trending Scientists

Recently Published Articles